- Services
- Therapeutic Areas
- Model Systems
- In Vitro
- In Vivo
- Technologies
- Service Type
- About Us
- Our Science
- Start Your Study Now
Cholangiocarcinoma, grade III, G2S1, with massive necrosis, and part of squamous metaplasia.IHC result: AFP(-), Hepa(-), CK7(100%++~+++), CK19(100%++~+++), CD34(vessel +), Ki-67(30%+), GP73(90%++), TG(-), P63(portion +), HCK(100%++~+++).
| Summary | |
|---|---|
| Cancer Type | cholangiocarcinoma |
| Subtype | ICC |
| Grade | III |
| Stage | NA |
| Ethnicity | Asian |
| Gender | F |
| Age | 63 |
| Pathology Diagnosis | Cholangiocarcinoma, grade III, G2S1, with massive necrosis, and part of squamous metaplasia.IHC result: AFP(-), Hepa(-), CK7(100%++~+++), CK19(100%++~+++), CD34(vessel +), Ki-67(30%+), GP73(90%++), TG(-), P63(portion +), HCK(100%++~+++). |
| Biopsy Site | Liver |
| Treatment History | NA |
| Pathology QC | Poorly differentiated adenocarcinoma (P4, P6) |
| Special Features | MYC amplified |
| Mouse Strain | Balb/c nu |
| TMA | NA |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P8 |
| Exome Seq | NA |
